New Developments in Therapy of Deep Mycoses.
نویسندگان
چکیده
منابع مشابه
New developments in the therapy of amoebiasis.
Progress report New developments in the therapy of amoebiasis Although frequently overlooked in practice, it has long been taught that for the adequate therapy of invasive amoebiasis treatment should be directed at all the sites where Entamoeba histolytica may be present. Hence the ideal amoebicide should be active within the bowel lumen, in the bowel wall, and systemically, particularly in the...
متن کاملNew developments in the therapy of intoxications.
There has been a significant evolution in the clinical management of the poisoned patient over the last decade. Interventions that were once the cornerstone of treating the poisoned patient have become passé or have come under intense scrutiny. The advent of evidence-based medicine has forced clinical scientists to re-evaluate standard therapies. Gastrointestinal decontamination with either eme...
متن کاملNew developments in the treatment of deep venous thrombosis
An initial course of standard heparin (SH) or low-molecular-weight heparins (LMWH) is regarded as the treatment of choice for patients with deep venous thrombosis (DVT). LMWH have better bioavailability after subcutaneous administra tion, have a longer half-life, and show higher and more predictable anticoagulant activity. As a result they can be given subcutaneously and without laboratory con...
متن کاملNew developments in the treatment of deep venous thrombosis
An initial course of standard heparin (SH) or low-molecular-weight heparins (LMWH) is regarded as the treatment of choice for patients with deep venous thrombosis (DVT). LMWH have better bioavailability after subcutaneous administra tion, have a longer half-life, and show higher and more predictable anticoagulant activity. As a result they can be given subcutaneously and without laboratory con...
متن کاملNew developments in the treatment of deep venous thrombosis
An initial course of standard heparin (SH) or low-molecular-weight heparins (LMWH) is regarded as the treatment of choice for patients with deep venous thrombosis (DVT). LMWH have better bioavailability after subcutaneous administra tion, have a longer half-life, and show higher and more predictable anticoagulant activity. As a result they can be given subcutaneously and without laboratory con...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nippon Ishinkin Gakkai Zasshi
سال: 2000
ISSN: 0916-4804,1882-0476
DOI: 10.3314/jjmm.41.221